1. Background {#sec30069}
=============

Many of serious and malignant disorders can initially present as a cervical mass; therefore, patients presenting with a head or neck mass need tissue biopsy to make a histological diagnosis and treatment plan. There have been developments in the diagnosis of head and neck masses in recent years. Many years ago when fine needle aspiration (FNA) was proposed, many studies were conducted to assess its accuracy rate ([@A10541R1]). Most head and neck masses are a result of a hyperplastic process, benign or malignant tumor. FNA has been routinely recommended for diagnosis ([@A10541R2]-[@A10541R4]). Most of these studies have confirmed that FNA is a safe, reliable, well tolerated, and inexpensive method for diagnosis in patients with cervical masses including thyroid and nonthyroid masses ([@A10541R5]). Due to the high rate of complications of open biopsy and surgery such as vascular complications (e.g. aneurysm), local spreading of the neoplasm, and cosmetic problems, surgeons sought a minimally invasive and atraumatic method for diagnosing tumoral masses ([@A10541R6]). In addition, some patients are not suitable candidate for any surgical procedure even a small open biopsy due to their general condition ([@A10541R7]). FNA cytology is a useful atraumatic technique for the first evaluation of cervical mass or nodule but its diagnostic accuracy and value in differentiation of neoplastic (including malignant or benign) and non-neoplastic masses is a debatable issue. The sensitivity of FNA in diagnosis of malignant mass ranges from 70% to 100% ([@A10541R3], [@A10541R8]). During recent years, FNA technique, devices including radiologic assisted FNA, and indications of this diagnostic procedure have improved. FNA is performed by physicians, pathologists, radiologists, general surgeons and otolaryngologists.

2. Objectives {#sec30070}
=============

In this study we evaluated the diagnostic accuracy of FNA in patients with nonthyroidal masses in the head and neck.

3. Patients and Methods {#sec30074}
=======================

3.1. Study Design and Participants {#sec30071}
----------------------------------

In a cross-sectional study 65 patients with head or neck masses (nonthyroid) referred to us from April 2004 to April 2009; they had both FNA and open biopsy (gold standard method) and were compared to assess specificity, sensitivity, positive and negative predictive values of FNA.

3.2. Sampling {#sec30072}
-------------

Aspiration was performed by an expert pathologist using a 22-gauge needle and a 20 mL syringe. There was no major complication observed after aspiration. Two or more specimens were obtained each time FNA was performed, and smears were directly prepared for cytology; after fixing via alcohol, smears were stained using Papanicolaou stain. Cytology of specimens obtained by FNA was followed by open biopsy during surgery, and the permanent diagnosis in every patient was made by histological study.

3.3. Ethics and Statistical Analysis {#sec30073}
------------------------------------

As a routine in this hospital, all subjects signed a form of informed consent before sampling. The study protocol was approved by the ethical and scientific committee of our university. SPSS version 16 was used for statistical analysis. Mean ± standard deviation (SD), t-test, ANOVA, and Chi-square tests were used for the analysis, and P \< 0.05 was considered as statistically significant. Also the sensitivity, specificity, positive predicting value, and negative predicting value were estimated using a diagnostic chart ([Table 1](#tbl8013){ref-type="table"}).

###### Chart Used for Estimating the Test Characteristics.

  FNA Findings ^[a](#fn5548){ref-type="table-fn"}^   Diagnosis by Open Biopsy   
  -------------------------------------------------- -------------------------- --------------------------
  **Test outcome abnormal**                          True Positive, 38 (67.8)   False positive, 3 (4.61)
  **Test outcome normal**                            False negative, 2 (3.07)   True negative, 22 (33.8)

^a^Abbreviation: FNA, fine needle aspiration

Statistical measures were estimated as follows; Sensitivity = True Positive/Abnormal in gold standard, Specificity = True Negative/ Normal in gold standard, Positive predictive value = True Positive/Observed Test Outcome Positive, Negative predictive value = True Negative/Observed Test Outcome Negative, Diagnostic Accuracy = True positive plus True negative/ All subjects.

4. Results {#sec30075}
==========

Sixty-five cases with both definite diagnoses of FNA and open biopsy were assessed. The mean (± SD) age of patients was 39.96 ± 19.69 years (from 10 to 82 years). Twenty-nine cases (44.6%) were females and 36 (55.4%) males. Regarding the results of open surgical biopsy; 25 (40.8%) subjects were categorized as malignant, 16 (19.4%) cases as benign, and 24 (39.8%) cases as non-neoplastic lesions ([Table 2](#tbl8014){ref-type="table"}).

###### Diagnosed Specimens

  Diagnosis                    No.   Subgroup, %   Total, %
  ---------------------------- ----- ------------- ----------
  **Malignant neoplasms**                          
  Basal cell carcinoma         1     4             1.5
  Adenocarcinoma               2     8             3
  Acinic cell carcinoma        1     4             1.5
  Clear cell carcinoma         1     4             1.5
  Hodgkin lymphoma             5     20            7.5
  Non-Hodgkin lymphoma         2     8             3
  Lymphoma                     3     12            4.5
  Metastatic carcinoma         10    40            15.4
  **Benign neoplasms**                             
  Pleomorphic adenoma          13    81.25         20
  Warthin tumor                1     6.25          1.5
  Lipoma                       2     12.5          3
  **Non-neoplastic lesions**                       
  Inflammatory process         2     8.33          3
  Granulomatous                3     12.5          4.5
  Branchial cyst               3     12.5          4.5
  Sialoadenitis                1     4.16          1.5
  Thyroglossal cyst            4     16.66         6
  Dermoid cyst                 1     4.16          1.5
  Globulomaxillary cyst        1     4.16          1.5
  Reactive lymphadenitis       9     37.4          13.8

The most common type of malignant neoplastic mass diagnosed was metastatic carcinoma (40%), and also the most common masses among benign neoplastic and benign masses were pleomorphic adenoma and reactive lymphadenitis (81.25% and 37.4%, respectively). The mean age between the three groups was significantly different, and post-HOC test demonstrated that the differences between the mean age of two groups of neoplastic (benign neoplastic = 43.62 ± 16.42 and malignant = 50.97 ± 22.31) and non-neoplastic (benign = 31.79 ± 15.58) were statistically significant (P \< 0.001). Six (12.24%) of 65 subjects were diagnosed incorrectly ([Table 3](#tbl8015){ref-type="table"}).

###### Diagnosis of Specimens Which Were Incorrect

  FNA Report ^[a](#fn5549){ref-type="table-fn"}^   Open Biopsy
  ------------------------------------------------ ------------------------
  Metastatic carcinoma                             Reactive lymphadenitis
  Pleomorphic adenoma                              Basal cell carcinoma
  Lymphoma                                         Reactive lymphadenitis
  Inflammatory process                             Metastatic carcinoma
  Reactive lymphadenitis                           Lymphoma

^a^Abbreviation: FNA, fine needle aspiration

There were 38 true positive, 22 true negative, 3 (4.61%) false positive and 2 (3.07%) false negative diagnoses by FNA for neoplastic masses. Therefore, the specificity, sensitivity, positive and also negative predictive values of FNA in the diagnosis of neoplastic mass were estimated as 85%, 95%, 92.68%, and 91.66%, respectively, and also the diagnostic accuracy was estimated as 92.3%.

5. Discussion {#sec30076}
=============

In this study, FNA cytology was performed in neck masses of the cervical region. Regarding the result, it seems that FNA is a useful atraumatic and minimally invasive technique with high diagnostic accuracy which can provide a highly sensitive diagnosis with low false positive and also low false negative diagnosis in patients with nonthyroid head or neck mass. In previous reports, FNA was effectively used for staging diseases and also designing a safe, less invasive and atraumatic management plan. FNA can prevent unnecessary, costly investigation in patients with a cervical mass ([@A10541R9]). The proportion of nondiagnostic procedures was 8.9% of all procedures(146 cases) which was similar to other previous studies ([@A10541R10]). Also, Mehrotra et al. reviewed the literature and reported a 5.0-43.1% unsatisfactory rate in the initial assessment of FNA cytology which was similar to our results ([@A10541R11]). In a similar study of thyroid and nonthyroid masses, Saatian et al., found the sensitivity and specificity of FNA lower than our findings which can be due to inclusion of thyroid masses in their investigation ([@A10541R8]). Also, our false negative proportion (3.07%) is much less than the Saatian et al. (26%) and QueHee et al. (39%) studies. On the other hand the proportion of false positive results for the diagnosis of malignant mass in our study was about 4% which is higher than Morgan et al. findings (0%) ([@A10541R12]).The differences in the results of various studies can be due to the technique of aspiration. Regarding the prevalence of malignant lesions in head and neck masses, the initial use of FNA cytology for the confirmation or exclusion of this diagnosis is mandatory. Some studies confirm that the accuracy of FNA can depend on the pathologic type of mass ([@A10541R13]). Also, Biopsy can enhance the diagnostic accuracy of FNA. Amedee et al., in a review article demonstrated that FNA followed by biopsy has a high overall accuracy of 87% for malignant mass, 95% for benign mass, and 95% for all head and neck ones ([@A10541R14]). In contrary, Addams-Williams et al., showed that FNA was highly sensitive for diagnosis of malignant lumps, but less good at confirming a benign lump ([@A10541R15]). Some techniques such as electron microscopy, flow cytometry, and immunohistochemistry were offered to increase the accuracy rate of FNA particularly for masses based on lymph nodes ([@A10541R16]). Also, ultrasound-guided FNA can reduce nondiagnostic rate ([@A10541R17]). Also, we found that patients with neck mass who were characterized as a malignant neoplasm were older than those diagnosed as nonmalignant (consistent with previous reports) ([@A10541R18]).On the other hand, in the present study the diagnosis of tubercular lymphadenitis was established in 4.5% which was much less than the values obtained in other studies in neighboring countries ([@A10541R2], [@A10541R13]). This difference can be due to the lower prevalence of tuberculosis in our country compared to our neighbors. Also, it was approved that the accuracy of FNA depends on operators experiences. Jandu et al., reported that the accuracy of FNA in head and neck mass was 91% when was performed by junior staff, and 100% when was performed by a consultant ([@A10541R19]). Moreover, we reviewed similar studies to evaluate the accuracy of FNA in the diagnosis of head and (or) neck masses, and the range of diagnostic accuracy was between 56% and 100%, the range of sensitivity 55% - 100%, and the range of specificity was 59% - 100% ([Table 4](#tbl8016){ref-type="table"}). FNB is newer than FNA, and is used in more advance stage or for more doubtful findings. Also, FNB is usually recommended when the result of FNA is not valid or suspicious. As seen in the literature review, the sensitivity, specificity and accuracy of FNA were different due to many different factors. The country and technology which is used in that country can affect the diagnostic accuracy. Also, experience can influence the result. This difference in diagnostic accuracy of FNA in various countries can be due to the experience of physicians and technology. Another reason for a wide difference in the FNA results is the location of the mass. Locating in a deeper and central site can decrease the accessibility for taking a biopsy. The target diagnosis can change the diagnosing accuracy. For example, in [Table 4](#tbl8016){ref-type="table"}, the accuracy of FNA is higher in cases which underwent biopsy for diagnosing malignancy. The age (adult or child) can change the sensitivity and specificity. An important factor is the year of study. As was said before, developing technology usually improves the accuracy of all tests. Moreover, our literature review showed that FNA is a minimally invasive procedure for the diagnosis of neck masses, although recently additional methods such as ultrasonography increase the diagnostic value ([@A10541R20]). Also, FNA as an atraumatic method can help to design an effective surgical plan ([@A10541R21]) in addition to identifying the tumor characteristics ([@A10541R22]).

###### Literature on Accuracy, Sensitivity, and Specificity of FNA^[a](#fn5389){ref-type="table-fn"}^

           Name                                                                 Year   Country     No.      Age, y     Location                 Accuracy, %   Sensitivity, %   Specificity, %   Mass
  -------- -------------------------------------------------------------------- ------ ----------- -------- ---------- ------------------------ ------------- ---------------- ---------------- -----------------------
  **1**    Our Study                                                            2012   Iran        65       Above 10   Neck                     92.3          95               85               Malignancy
  **2**    Santos et al. ([@A10541R23]) ^[b](#fn5390){ref-type="table-fn"}^     2011   Brazil      50       Above 10   Oral, Head & neck        58.8          75               96               Benign
  **3**    Saatian et al. ([@A10541R8])                                         2011   Iran        100      42.6       Neck                     79            72               87               Metastatic malignancy
  **4**    Carr et al. ([@A10541R24])                                           2010   UK          NA       Adults     Head and neck            87            85               91               Lymph nodes
  **5**    Kuvezdic et al. ([@A10541R25])                                       2010   Croatia     100      All        Head and neck            NA            90               88               Lymphoma
  **6**    Moatamed et al. ([@A10541R26])                                       2009   US          92       All        Head and neck            NA            76               100              Cyst
  **7**    Addams-Williams et al. ([@A10541R15])                                2009   UK          625      Above3     Non-Thyroid neck lumps   88 - 66       92               90               Malignant
  **8**    Hirachand ([@A10541R3])                                              2009   Nepal       130      3-85       Head and neck            NA            100              100              Metastatic carcinoma
  **9**    Carrillo et al. ([@A10541R27]) ^[b](#fn5390){ref-type="table-fn"}^   2009   Mexico      NA       All        Parotid mass             NA            92               98               Malignancy
  **10**   Anne et al. ([@A10541R28]) ^[b](#fn5390){ref-type="table-fn"}^       2008   US          71       8.4        Head and neck            92            100              85               Malignancy
  **11**   Tandon et al. ([@A10541R29])                                         2008   UK          Review   All        Head and neck            95.1          89.5             98.5             Malignancy
  **12**   Hernandez et al. ([@A10541R30])                                      2008   Colombia    46       All        Parotid mass             48            54               90               Cancer
  **13**   Arabi et al. ([@A10541R31]) ^[c](#fn5391){ref-type="table-fn"}^      2008   US          31       All        Head and neck            NA            97               100              Malignancy
  **14**   Gonzalez et al.([@A10541R32])                                        2008   Spain       172      All        Head and neck            NA            95.8             98.11            Malignancy
  **15**   Howlett et al. ([@A10541R17])                                        2007   UK          143      Adult      Head and neck            NA            89               57               Overall
  **16**   Martinek et al. ([@A10541R33])                                       2004   Czech       245      All        Thyroid nodules          86            90               85               Malignancy
  **17**   Morgan et al. ([@A10541R12])                                         2003   Australia   253      All        Thyroid nodules          67.2          55               73.7             Malignancy
  **18**   El Hag ([@A10541R13])                                                2003   SA          225      All        Head and neck            NA            95               96               Cancer
  **19**   Contucci et al. ([@A10541R34]) ^[b](#fn5390){ref-type="table-fn"}^   2003   Italy       146      All        Parotid mass             94            57.2             100              Malignancy
  **20**   Tilak et al. ([@A10541R35])                                          2002   India       55       NA         Head and neck            92.73         90.91            93.18            Overall
  **21**   Tilac et al. ([@A10541R35])                                          2002   India       55       All        Head and neck            92.7          90.9             93.1             Overall
  **22**   Arda et al. ([@A10541R9]) ^[b](#fn5390){ref-type="table-fn"}^        2001   Turkey      46       child      Thyroid                  59            60               59               Thyroid nodules
  **23**   Quehee et al. ([@A10541R10])                                         2001   Australia   169      All        Parotid mass             56            57               100              Malignancy
  **24**   Amedee et al. ([@A10541R14]) ^[b](#fn5390){ref-type="table-fn"}^     2001   U.S         Review   adult      Head and neck            95            NA               NA               Overall
  **25**   Mehrvarz and Sangsari ([@A10541R36])                                 2001   Iran        95       adult      Thyroid nodules          NA            78               92               Overall
  **26**   Bakhos et al. ([@A10541R37])                                         2000   US          625      All        Thyroid nodules          87            93               96               Malignancy
  **27**   Jandu et al. ([@A10541R19])                                          1999   UK          95       All        Head and neck            91-100        90               97               Malignancy
  **28**   Al-Khafaji et al. ([@A10541R38])                                     1998   US          154      All        Parotid mass             84            82               86               Malignancy

^a^Abbreviations: FNA, fine needle aspiration; NA, not available; SA, Saudi Arabia; y, year

^b^FNA findings confirmed by fine needle biopsy

^c^FNA during the operation

None declared.

**Implication for health policy/practice/research/medical education:**

There are many reports regarding the accuracy and applicability of FNA in diagnosis of nodular lesions. We assess the use of FNA in nonthyroidal head and neck masses.
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